DK3323811T3 - Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse - Google Patents
Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse Download PDFInfo
- Publication number
- DK3323811T3 DK3323811T3 DK16824515.7T DK16824515T DK3323811T3 DK 3323811 T3 DK3323811 T3 DK 3323811T3 DK 16824515 T DK16824515 T DK 16824515T DK 3323811 T3 DK3323811 T3 DK 3323811T3
- Authority
- DK
- Denmark
- Prior art keywords
- heterocyclic compound
- containing heterocyclic
- nitrogen containing
- preparing
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015141034A JP6412471B2 (ja) | 2015-07-15 | 2015-07-15 | 含窒素複素環化合物の製造方法およびその中間体 |
PCT/JP2016/070758 WO2017010535A1 (ja) | 2015-07-15 | 2016-07-14 | 含窒素複素環化合物の製造方法およびその中間体 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3323811T3 true DK3323811T3 (da) | 2019-07-22 |
Family
ID=57758235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16824515.7T DK3323811T3 (da) | 2015-07-15 | 2016-07-14 | Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse |
Country Status (21)
Country | Link |
---|---|
US (2) | US10435377B2 (da) |
EP (1) | EP3323811B1 (da) |
JP (1) | JP6412471B2 (da) |
KR (1) | KR102032140B1 (da) |
CN (1) | CN107848987B (da) |
AU (1) | AU2016294197B2 (da) |
BR (1) | BR112018000759A2 (da) |
CA (1) | CA2992403C (da) |
DK (1) | DK3323811T3 (da) |
ES (1) | ES2729958T3 (da) |
HK (1) | HK1245268A1 (da) |
IL (1) | IL256809B (da) |
MX (1) | MX2018000459A (da) |
NZ (1) | NZ738953A (da) |
PL (1) | PL3323811T3 (da) |
RU (1) | RU2717830C2 (da) |
SG (1) | SG11201800245QA (da) |
TR (1) | TR201909774T4 (da) |
TW (1) | TWI711605B (da) |
WO (1) | WO2017010535A1 (da) |
ZA (1) | ZA201800269B (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202027749A (zh) | 2018-10-12 | 2020-08-01 | 日商富士軟片股份有限公司 | 急性骨髓性白血病用抗腫瘤劑 |
EP3875088A4 (en) * | 2018-10-31 | 2021-12-29 | FUJIFILM Corporation | Package for medical composition containing anti-tumor agent |
EP3875090A4 (en) * | 2018-10-31 | 2021-12-22 | FUJIFILM Corporation | PELLET CONTAINING AN ANTITUMOR AGENT |
TW202045174A (zh) | 2019-02-28 | 2020-12-16 | 日商富士軟片股份有限公司 | 組合醫藥 |
TW202340177A (zh) | 2021-12-30 | 2023-10-16 | 美商拜歐米富士恩股份有限公司 | 作為 flt3抑制劑之吡嗪化合物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8928839D0 (en) | 1989-12-21 | 1990-02-28 | Beecham Group Plc | Novel compounds |
ES2314106T3 (es) | 2001-10-17 | 2009-03-16 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Derivados de pirimidina, agentes farmaceuticos que contiene dichos compuestos, uso y metodo para su obtencion. |
KR101312225B1 (ko) | 2005-06-08 | 2013-09-26 | 리겔 파마슈티칼스, 인크. | Jak 경로의 억제를 위한 조성물 및 방법 |
US20060281755A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators |
US8071768B2 (en) * | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
EP3173084B1 (en) | 2005-11-11 | 2019-10-23 | Boehringer Ingelheim International GmbH | Quinazoline derivatives for the treatment of cancer diseases |
PL2001892T3 (pl) | 2006-03-17 | 2013-09-30 | Ambit Biosciences Corp | Imidazolotiazolowe związki do leczenia chorób proliferacyjnych |
EP2022785A1 (en) * | 2007-06-20 | 2009-02-11 | Bayer Schering Pharma Aktiengesellschaft | Alkynylpyrimidines as Tie2 kinase inhibitors |
WO2009095399A2 (en) | 2008-02-01 | 2009-08-06 | Akinion Pharmaceuticals Ab | Pyrazine derivatives and their use as protein kinase inhbitors |
EP2578601A1 (en) | 2008-03-14 | 2013-04-10 | Allergan, Inc. | Immuno-based botulinum toxin serotype A activity assays |
NO2300013T3 (da) | 2008-05-21 | 2018-02-03 | ||
JP5918693B2 (ja) | 2009-05-05 | 2016-05-18 | ダナ ファーバー キャンサー インスティテュート インコーポレイテッド | Egfr阻害剤及び疾患の治療方法 |
US9290485B2 (en) | 2010-08-04 | 2016-03-22 | Novartis Ag | N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
US9238629B2 (en) | 2010-11-01 | 2016-01-19 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
JP5957003B2 (ja) | 2010-11-10 | 2016-07-27 | セルジーン アヴィロミクス リサーチ, インコーポレイテッド | 変異体選択的egfr阻害剤およびその使用 |
US8703767B2 (en) | 2011-04-01 | 2014-04-22 | University Of Utah Research Foundation | Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors |
AU2011367222B2 (en) | 2011-05-04 | 2017-04-13 | Forma Tm, Llc | Novel compounds and compositions for the inhibition of NAMPT |
JP2013157540A (ja) | 2012-01-31 | 2013-08-15 | Toshiba Corp | 半導体装置およびその製造方法 |
NO2840080T3 (da) * | 2012-04-17 | 2018-05-05 | ||
EP3059227B1 (en) * | 2013-10-16 | 2019-06-26 | FUJIFILM Corporation | Salt of nitrogen-containing heterocyclic compound or crystal thereof, pharmaceutical composition, and flt3 inhibitor |
KR20150056683A (ko) | 2013-11-15 | 2015-05-27 | (주) 제일피앤티 | 대전 방지 필름 및 이를 이용한 쉴드 백 |
WO2016027904A1 (ja) | 2014-08-22 | 2016-02-25 | 富士フイルム株式会社 | Flt3変異陽性癌を処置するための医薬組成物、変異型flt3阻害剤およびそれらの応用 |
-
2015
- 2015-07-15 JP JP2015141034A patent/JP6412471B2/ja active Active
-
2016
- 2016-07-14 EP EP16824515.7A patent/EP3323811B1/en active Active
- 2016-07-14 KR KR1020187000990A patent/KR102032140B1/ko active IP Right Grant
- 2016-07-14 BR BR112018000759-5A patent/BR112018000759A2/pt active Search and Examination
- 2016-07-14 DK DK16824515.7T patent/DK3323811T3/da active
- 2016-07-14 PL PL16824515T patent/PL3323811T3/pl unknown
- 2016-07-14 CN CN201680041023.4A patent/CN107848987B/zh active Active
- 2016-07-14 CA CA2992403A patent/CA2992403C/en active Active
- 2016-07-14 AU AU2016294197A patent/AU2016294197B2/en active Active
- 2016-07-14 TW TW105122147A patent/TWI711605B/zh active
- 2016-07-14 RU RU2018100967A patent/RU2717830C2/ru active
- 2016-07-14 MX MX2018000459A patent/MX2018000459A/es unknown
- 2016-07-14 WO PCT/JP2016/070758 patent/WO2017010535A1/ja active Application Filing
- 2016-07-14 ES ES16824515T patent/ES2729958T3/es active Active
- 2016-07-14 NZ NZ738953A patent/NZ738953A/en unknown
- 2016-07-14 SG SG11201800245QA patent/SG11201800245QA/en unknown
- 2016-07-14 TR TR2019/09774T patent/TR201909774T4/tr unknown
-
2018
- 2018-01-09 IL IL256809A patent/IL256809B/en active IP Right Grant
- 2018-01-10 US US15/867,122 patent/US10435377B2/en active Active
- 2018-01-15 ZA ZA2018/00269A patent/ZA201800269B/en unknown
- 2018-04-11 HK HK18104741.4A patent/HK1245268A1/zh unknown
-
2019
- 2019-02-11 US US16/272,263 patent/US10562862B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3286181T3 (da) | Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne | |
DK3283107T3 (da) | Sammensætninger omfattende en kombination af ipilimumab og nivolumab | |
DK3340981T3 (da) | Aryl, heteroaryl og heterocykliske forbindelser til behandling af medicinske forstyrrelser | |
MA45940A (fr) | Composé hétérocyclique | |
DK3555070T3 (da) | Aminsubstituerede, heterocykliske forbindelser som ehmt2-hæmmere og fremgangsmåder til anvendelse deraf | |
DK3185868T3 (da) | Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme | |
DK3376859T3 (da) | Mikroorganismer til fremstilling af insektferomoner og relaterede forbindelser | |
DK3317400T3 (da) | Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter | |
DK3277270T3 (da) | Sammensætninger og fremgangsmåder til behandling af anæmi | |
DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
DK3294865T3 (da) | Fremgangsmåder til fremstilling af epimeraser og benzylisoquinolinalkaloider | |
DK3519572T3 (da) | Forbindelser og fremgangsmåder til reduktion af tau-ekspression | |
DK3271347T3 (da) | Antifungale forbindelser og fremstillingsfremgangsmåder | |
DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
DK3178324T3 (da) | Mikrobicid og fremgangsmåde til fremstilling af samme | |
DK3484524T3 (da) | Forbindelser og fremgangsmåder til modulation af smn2 | |
DK3323811T3 (da) | Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse | |
DK3529233T3 (da) | Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider | |
DK3224354T3 (da) | Manipulerede iminreductaser og fremgangsmåder til den reduktive aminering af keton- og aminforbindelser | |
DK3255046T3 (da) | Hydroxyethylsulfonat af cyclin-afhængig proteinkinasehæmmer, krystallinsk form deraf og fremgangsmåde til fremstilling deraf | |
DK3244785T3 (da) | Sugeindretning og fremgangsmåde til drift af en sugeindretning | |
DK3265443T3 (da) | Pyrrolidincarboxamidderivater og fremgangsmåde til fremstilling og anvendelse af samme | |
DK3519394T3 (da) | Fremgangsmåde til fremstilling af den krystallinske form af modifikation a af calcobutrol | |
DK3630752T3 (da) | Substituerede nitrogenholdige forbindelser | |
DK3347342T3 (da) | Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner |